Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Viral contamination in biologic manufacture and implications for emerging therapies
2020
199 citations
Review
Field-Weighted Citation Impact:
2.97
·
Sanofi (France)
Dayue Chen
·
Eli Lilly (United States)
Ming Chong
·
CSL (Australia)
Houman Dehghani
·
Amgen (United States)
Lionel Gérentes
·
Sanofi (France)
James W. Gilbert
·
Biogen (United States)
D. Dryburgh Gold
·
BioMarin (United States)
Róbert Kiss
·
Sutro Biopharma (United States)
Thomas R. Kreil
·
Baxter (Austria)
René Labatut
·
Sanofi (France)
Yuling Li
·
Zhejiang Lab
Jürgen Müllberg
·
Bristol-Myers Squibb (United States)
Laurent Mallet
·
Sanofi (France)
Christian Menzel
·
Merck Serono (Switzerland)
Mark D. Moody
·
Merrimack Pharmaceuticals (United States)
Serge Monpoeho
·
Regeneron (United States)
Marie Murphy
·
Eli Lilly (United States)
Mark Plavsic
·
Sanofi (United States)
Nathan Roth
·
CSL (Switzerland)
David J. Roush
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
M. Ruffing
·
Boehringer Ingelheim (Germany)
Richard Schicho
·
Bristol-Myers Squibb (United States)
Richard Snyder
Daniel Stark
·
Novartis (Switzerland)
Chun Zhang
·
Takeda (United States)
Jacqueline M. Wolfrum
·
Massachusetts Institute of Technology
Anthony J. Sinskey
·
Massachusetts Institute of Technology
Stacy L. Springs
·
Massachusetts Institute of Technology
Viral contamination in biologic manufacture and implications for emerging therapies | Researchclopedia